Women with adenomyosis who fail repeated IVF transfers are often missing one key step: 2 to 4 months of GnRH agonist therapy before the embryo transfer. This chemically suppresses estrogen, quiets adenomyosis-driven uterine contractions, and meaningfully improves live birth rates.